rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2004-12-20
|
pubmed:abstractText |
Leukemia stem cells are defined as transformed hematopoietic stem cells or committed progenitor cells that have amplified or acquired the stem cell capacity for self-renewal, albeit in a poorly regulated fashion. In this issue of Cancer Cell, Huntly and colleagues report a striking difference in the ability of two leukemia-associated fusion proteins, MOZ-TIF2 and BCR-ABL, to transform myeloid progenitor populations. This rigorous study supports the idea of a hierarchy among leukemia-associated protooncogenes for their ability to endow committed myeloid progenitors with the self-renewal capacity driving leukemic stem cell propagation, and sheds new light on the pathogenesis of chronic and acute myelogenous leukemias.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CTNNB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cytoskeletal Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Fusion Proteins, bcr-abl,
http://linkedlifedata.com/resource/pubmed/chemical/MLL-ENL oncoprotein, human,
http://linkedlifedata.com/resource/pubmed/chemical/MOZ-TIF2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Myeloid-Lymphoid Leukemia Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Fusion,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/beta Catenin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1535-6108
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
531-3
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15607956-Acute Disease,
pubmed-meshheading:15607956-Cell Differentiation,
pubmed-meshheading:15607956-Cell Transformation, Neoplastic,
pubmed-meshheading:15607956-Cytoskeletal Proteins,
pubmed-meshheading:15607956-Fusion Proteins, bcr-abl,
pubmed-meshheading:15607956-Hematopoietic Stem Cells,
pubmed-meshheading:15607956-Humans,
pubmed-meshheading:15607956-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:15607956-Leukemia, Myeloid,
pubmed-meshheading:15607956-Models, Biological,
pubmed-meshheading:15607956-Myeloid Progenitor Cells,
pubmed-meshheading:15607956-Myeloid-Lymphoid Leukemia Protein,
pubmed-meshheading:15607956-Neoplastic Stem Cells,
pubmed-meshheading:15607956-Oncogene Proteins, Fusion,
pubmed-meshheading:15607956-Proto-Oncogenes,
pubmed-meshheading:15607956-Trans-Activators,
pubmed-meshheading:15607956-beta Catenin
|
pubmed:year |
2004
|
pubmed:articleTitle |
Chronic versus acute myelogenous leukemia: a question of self-renewal.
|
pubmed:affiliation |
Institute of Cancer and Stem Cell Biology and Medicine, Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Comment
|